kras mutation and glutathion KRAS-Mutant Lung Cancer: Targeting Molecular Immunologic Pathways, Therapeutic Advantages and Restrictions The KRAS-G12D mutation induces metabolic
The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect Overcoming resistance to drugs targeting KRASG12C mutation KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16





